Literature DB >> 19054821

Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations.

A M Valdes1, T D Spector, S Doherty, M Wheeler, D J Hart, M Doherty.   

Abstract

BACKGROUND: Variants in the growth differentiation factor 5 (GDF5) and in the double von Willebrand factor A (DVWA) have recently been reported to be associated with osteoarthritis (OA) in Asian populations.
OBJECTIVE: To assess the role of such variants in OA susceptibility in two independent UK samples of Caucasian origin.
METHODS: Polymorphisms rs11718863 and rs7639618 (DVWA) and rs143383 (GDF5) were genotyped in 999 patients with knee OA, 843 patients with hip OA and 1166 controls from two UK studies from Nottingham and Chingford.
RESULTS: In agreement with previous reports, the major allele at rs143383 (GDF5) was associated with a higher risk of knee OA in our samples (OR(MH) = 1.29, 95% CI 1.14 to 1.47 p = 8 x 10(-5)). Conversely, the major allele at the DVWA SNP rs7639618, which increased risk in Asians, was not associated with a risk of knee OA, (OR(MH) = 0.88, 95% CI 0.74 to 1.04; p = 0.12). A meta-analysis of Asian and UK knee OA data indicated highly significant heterogeneity (I(2) = 92%, Q = 48.5, p = 7 x 10(-10)) and no significant association with knee OA using a random effects meta-analysis (OR(DL) = 1.18, 95% CI 0.86 to 1.63; p = 0.309).
CONCLUSIONS: These data confirm that the GDF5 variant is consistently associated with the risk of knee OA. Considerable ethnic variation in allele frequencies at the DVWA gene was found and no significant association was found in UK samples or by combining UK and Asian samples. The results suggest that the effect of DVWA amino acid changes on tubulin binding is unlikely to influence the risk of OA in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054821     DOI: 10.1136/ard.2008.102236

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

Review 1.  Genetic epidemiology of hip and knee osteoarthritis.

Authors:  Ana M Valdes; Tim D Spector
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

2.  Association between genetic variants of DVWA and osteoarthritis of the knee and hip: a comprehensive meta-analysis.

Authors:  Rui Zhang; Jianfeng Yao; Peng Xu; Baohu Ji; Géraldine Voegeli; Weikun Hou; Hui Li; Yi Wang; John R Kelsoe; Jie Ma
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Genetic influence of growth and differentiation factor 5 gene polymorphism (+104T/C) on the development of knee osteoarthritis and its association with disease severity.

Authors:  Mervat I Abd Elazeem; Enas Abolkheir Abdelaleem; Rabab A Mohamed
Journal:  Eur J Rheumatol       Date:  2017-06-01

4.  The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance.

Authors:  Ana M Valdes; Evangelos Evangelou; Hanneke J M Kerkhof; Agu Tamm; Sally A Doherty; Kalle Kisand; Ann Tamm; Irina Kerna; Andre Uitterlinden; Albert Hofman; Fernando Rivadeneira; Cyrus Cooper; Elaine M Dennison; Weiya Zhang; Kenneth R Muir; John P A Ioannidis; Margaret Wheeler; Rose A Maciewicz; Joyce B van Meurs; Nigel K Arden; Tim D Spector; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2010-09-24       Impact factor: 19.103

5.  A SNP in the 5'UTR of GDF5 is associated with susceptibility to symptomatic lumbar disc herniation in the Chinese Han population.

Authors:  Jihong Mu; Weiming Ge; Xincheng Zuo; Yuxuan Chen; Changlin Huang
Journal:  Eur Spine J       Date:  2013-10-09       Impact factor: 3.134

Review 6.  A comprehensive meta-analysis of association between genetic variants of GDF5 and osteoarthritis of the knee, hip and hand.

Authors:  Rui Zhang; Jianfeng Yao; Peng Xu; Baohu Ji; James V Luck; Brian Chin; Shemin Lu; John R Kelsoe; Jie Ma
Journal:  Inflamm Res       Date:  2015-04-17       Impact factor: 4.575

Review 7.  Genome Engineering for Osteoarthritis: From Designer Cells to Disease-Modifying Drugs.

Authors:  Yun-Rak Choi; Kelsey H Collins; Jin-Woo Lee; Ho-Jung Kang; Farshid Guilak
Journal:  Tissue Eng Regen Med       Date:  2019-01-05       Impact factor: 4.169

8.  Personalized medicine for osteoarthritis: where are we now?

Authors:  Allen Dale Sawitzke
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-04       Impact factor: 5.346

9.  First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis.

Authors:  Virginia B Kraus; Thomas B Kepler; Thomas Stabler; Jordan Renner; Joanne Jordan
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

Review 10.  Developments in the scientific understanding of osteoarthritis.

Authors:  Steven B Abramson; Mukundan Attur
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.